Fellowship · Boston, MA
Sponsored by Mass General Brigham
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · John Schorge
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 349 citations · Kerry Rodabaugh, John Schorge
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 350 citations · Ursula Matulonis
Clinical and translational advances in ovarian cancer therapy.
Nature cancer · 2023 · 348 citations · Ursula Matulonis
Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update.
Gynecologic oncology · 2023 · 160 citations · Kevin Elias
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 346 citations ·
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 89 citations · Mitchell Edelson
Diagnosis and management of gestational trophoblastic disease: 2021 update.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2021 · 212 citations · Ross Berkowitz